GenomeWeb quotes Andrew Adey, Ph.D., in a story about a new method for single-cell sequencing. He says, “The single-cell Hi-C space has lagged behind in some sense because interoperability of data is challenging. That’s where these coassays are valuable, particularly if they root their analysis in RNA.”

A story in Health Central notes that muscle weakness caused by multiple sclerosis can lead to problems with lung function, swallowing and related issues. Vijayshree Yadav, M.D., says, “Any time we suspect a patient’s breathing is compromised, we recommend a lung function test, which is a standardized test done at a pulmonary clinic.”

In an OHSU News story about a landmark $16.4 million grant from the National Institute of Mental Health to the OHSU Center for Mental Health Innovation, Bonnie Nagel, Ph.D., says, “We consider this a formative grant in achieving the mission of the center, which is to advance scientific discoveries in mental health and rapidly translate those into real-world practices.”

HealthDay writes about Todd Vogt, an OHSU patient with early-onset Parkinson’s disease who will compete for the U.S. in rowing during the Paralympic Games. Lauren Talman, M.D., says, “Todd is not just a remarkable athlete, but an inspiration to many. I will be cheering for him as a fan this summer in Paris, proud of how far he has come and excited to see what he accomplishes next.”

A Globe Newswire press release issued by the Chiesi Group announces that Maria Fleseriu, M.D., will present analysis of clinical trial results of an oral octreotide capsule in the treatment of acromegaly, a pituitary disorder.

Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D., are quoted in an OHSU News story about a first-of-its-kind drug that inhibits a protein that works as a signaling point in many different types of cancers, an example of the mission of the Center for Experimental Therapeutics in the OHSU Knight Cancer Institute. Kummar says, “The center was set up to bring discoveries from the lab to the clinic.”

In a UPI story about a survey revealing only half of U.S. residents have basic first aid training, Heather Wong, RN, endorses hands-only CPR, which, she says, “is less exhausting and easier to do if they are concerned about providing rescue breathing.”

Medscape covers promising results from a pilot study using focused ultrasound to create a lesion in the brain’s thalamus to treat trigeminal neuralgia, a painful chronic condition affecting a nerve in the face. Mary Heinricher, Ph.D., says, “Evidence that focused ultrasound targeting central lateral nucleus has the potential to provide relief is both a source of hope for these patients and likely tells us something about how this circuit has gone wrong. That information could put us on a path to better mechanistic understanding, which in turn, could lead to improved treatment.”

Wine Business Monthly highlights Hillsboro Medical Center’s longstanding ¡Salud! program to provide attainable, affordable health care to vine tenders with the support of the Hillsboro Medical Center Foundation. Leda Garside, RN, says, “We have our own mobile medical units, launched mobile mental health services by bilingual clinical psychologists, and established electronic medical records, which allows us, and other providers, to see services provided and follow-up plans.”

Scientific American republishes an Undark magazine story about a genetically engineered bacteria sold to prevent dental cavities. Jonathon Baker, Ph.D., notes that some bacteria, including Streptococcus mutans, can make both acid and biofilms — and that “it’s definitely possible” for this new, engineered bacteria to spread within families and cohabitating people.